HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain (vol 19, pg 2115, 2022)-MedSci.cn

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain (vol 19, pg 2115, 2022)

Deng, QF; Luo, L; Quan, Z; Liu, NJ; Du, ZB; Sun, W; Luo, CL; Wu, XH

MOLECULAR MEDICINE REPORTS, 2022; 26 (1):

科室
- - 订阅+
  - 更多科室
工具
服务